Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Attributable Risks For Familial Breast Cancer By Proband Status And Morphology: A Nationwide Epidemiologic Study From Sweden

K. Hemminki, C. Granström, K. Czene
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Population attributable factions (PAFs) show the proportion of the disease that could be prevented if the cause could be removed. The PAF for familial breast cancer has not been precisely determined. We used the nationwide Swedish Family‐Cancer Database on 10.2 million individuals and 190,000 mothers' and 26,000 daughters' breast cancers to calculate familial standardized incidence ratios (SIRs), proportion of cases with a family history and familial PAFs for all invasive and in situ and morphology‐specific breast cancers in daughters who were 0–66 years old. The data were calculated by mother only, sister only or both as probands. More than 5,500 familial breast cancers were recorded. The familial SIRs for all invasive breast cancer were 1.79 by breast cancer in the mother only, 2.03 by breast cancer in a sister only and 2.82 by breast cancer in both a mother and sister. The familial PAFs were 3.61, 3.01 and 0.43%, respectively, giving a total PAF of 7.05%. Age‐specific risks were shown for the mother and sister history of breast cancer. The PAF values decreased by age when the daughter had a mother history of breast cancer but not when she had a sister history. PAFs did not depend on the morphologic type of breast cancer. The data show that the familial PAF of breast cancer among a 0–66‐year‐old population of daughters was 7% and independent of the morphologic type. If contribution from the paternal side was allowed for, the PAF would be 11%. © 2002 Wiley‐Liss, Inc.
This paper references
10.1016/S0959-8049(00)00093-9
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?
H. Eerola (2000)
The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches.
N. Risch (2001)
10.1056/NEJM200007133430201
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P. Lichtenstein (2000)
10.1038/82533
High constant incidence in twins and other relatives of women with breast cancer
J. Peto (2000)
10.1073/pnas.012584499
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium
D. Thompson (2002)
10.1001/JAMA.1993.03510030062035
Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study.
G. Colditz (1993)
Correspondence re: Risch, N.: Genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol. Biomark. Prev., 10: 733-741, 2001.
K. Hemminki (2002)
10.1093/JNCI/92.18.1529
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.
K. Syrjäkoski (2000)
Nevanlinna H. Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients
K Syrjäkoski (2000)
10.1093/JNCI/93.23.1811
Breast carcinoma in situ: risk factors and screening patterns.
E. Claus (2001)
10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B
Family history and the risk of breast cancer: A systematic review and meta‐analysis
P. Pharoah (1997)
Genetic epidemiology of breast
K Hemminki (1994)
10.1186/bcr444
Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?
K. Hemminki (2002)
Cancer epidemiology: principles and methods
I. dos Santos Silva (1999)
10.1016/S0959-8049(00)00023-X
Familial predisposition to breast cancer in a British population: implications for prevention.
P. Pharoah (2000)
Genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches Cancer Epidemiol. Biomark
K. Hemminki (2002)
Philadelphia: Lippincott-Raven
K Rothman (1998)
10.1080/02841860152619214
The nation-wide Swedish family-cancer database--updated structure and familial rates.
K. Hemminki (2001)
10.1093/JNCI/91.11.916
Colorectal cancer: molecules and populations.
J. Potter (1999)
Familial breast cancer risks by morphology : a nation - wide epidemiologic study from Sweden
K Hemminki (1998)
10.1093/JNCI/87.22.1681
Proportion of breast cancer cases in the United States explained by well-established risk factors.
M. P. Madigan (1995)
10.1093/JNCI/90.15.1138
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
S. Lakhani (1998)
10.1093/OXFORDJOURNALS.AJE.A115616
Age at onset as an indicator of familial risk of breast cancer.
E. Claus (1990)
Profiling familial breast can
Lakhani (2001)
10.1093/JNCI/93.2.121
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.
J. Olsen (2001)
Modern epidemiology, 2nd ed
K Rothman (1998)
10.1136/jcp.47.1.95-d
Basic Pathology
W. Roche (1994)
10.1054/bjoc.2000.1585
Sibling risks in cancer: clues to recessive or X-linked genes?
K. Hemminki (2001)
Familial breast cancer risks by morphology: a nation-wide epidemiologic study from Sweden. Cancer
K Hemminki
Gene-expression profiles in hereditary breast cancer.
J. Sudbø (2001)
Genetic analysis of breast cancer in the cancer and steroid hormone study.
E. Claus (1991)
10.1093/JNCI/91.11.943
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
J. Peto (1999)
Morphological types of breast cancer in family members and multiple primary tumours : is morphology an inherited trait ?
K Hemminki
10.1080/028418601750288145
Genetic Epidemiology--science and ethics on familial cancers.
K. Hemminki (2001)
10.1002/ijc.1473
Familial carcinoid tumors and subsequent cancers: A nation‐wide epidemiologic study from Sweden
K. Hemminki (2001)
10.1016/S0140-6736(01)06524-2
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease
P. Brandt (2001)
10.1001/JAMA.1993.03510130069033
A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database.
M. Slattery (1993)
10.1086/324471
Large upward bias in estimation of locus-specific effects from genomewide scans.
H. Göring (2001)
10.1093/AJE/152.12.1154
Familial breast and ovarian cancer: a Swedish population-based register study.
H. Anderson (2000)
10.1086/318187
After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer.
J. Cui (2001)
10.1002/1098-2272(200102)20:2<247::AID-GEPI7>3.0.CO;2-U
Cancer risks to spouses and offspring in the family‐cancer database
K. Hemminki (2001)
10.1002/1097-0215(20001215)88:6<998::AID-IJC25>3.0.CO;2-0
Risk factors and age‐incidence relationships for contralateral breast cancer
P. Vaittinen (2000)
10.1056/NEJM199205143262004
Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer.
T. A. Sellers (1992)
10.1080/08858199709528465
The reliability of recollections of family history: implications for the medical provider.
M. Parent (1997)
10.1073/pnas.191367098
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T. Sørlie (2001)
10.1038/86464
Profiling familial breast cancer
S. Lakhani (2001)
10.1073/PNAS.97.17.9603
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.
T. Kainu (2000)
10.1093/OXFORDJOURNALS.AJE.A121617
Proportion of disease caused or prevented by a given exposure, trait or intervention.
O. Miettinen (1974)
10.1016/S0140-6736(01)06524-2
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease
Collaborative Group on Hormonal Factors in Breast Cancer (2001)
10.1002/CNCR.2820741312
Genetic epidemiology of breast cancer
Douglas W. Thompson (1994)
10.1002/cncr.10555
Familial breast carcinoma risks by morphology
K. Hemminki (2002)
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.
S. Lakhani (2000)



This paper is referenced by
10.1097/00005650-200301001-00008
Information System Concepts for Quality Measurement
B. James (2003)
Assessment of Predictive Confounders for the Prevalence of Breast Cancer among Iraqi Population: A Retrospective Study from Baghdad, Iraq
N. H. Mohammed (2019)
10.1186/bcr2260
A constant risk for familial breast cancer? A population-based family study
K. Czene (2008)
10.1093/ANNONC/MDH072
Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results
H. Verkooijen (2004)
10.1186/bcr940
Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast
E. de Villiers (2004)
10.1093/carcin/bgn253
A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
S. Tchatchou (2009)
factor AKAP13 with familial breast cancer
M. Wirtenberger (2005)
10.1097/EDE.0b013e31805d8ab2
“Population Lab”: The Creation of Virtual Populations for Genetic Epidemiology Research
M. Leu (2007)
10.1038/NG1002-233
Risk for familial breast cancer increases with age
K. Hemminki (2002)
10.1007/s10552-008-9181-2
Family history of malignancies and risk of breast cancer: prospective data from the Shanghai women’s health study
Briseis A. Kilfoy (2008)
10.1093/annonc/mdn527
Age of onset in familial cancer.
A. Brandt (2008)
Inheritance and the Risk of Breast Cancer
(2010)
HUMAN PAPILLOMA VIRUS IN BREAST EPITHELIUM Table 3 : HPV 16-RNA expression in control and DC patients
M. Mohamed (2015)
10.1007/s10549-007-9814-2
Population attributable risks for breast cancer in Swedish women by morphological type
C. Granström (2007)
10.1159/000184707
Chromosome copy number variation and breast cancer risk
S. Tchatchou (2008)
Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP 13 with familial breast cancer
M. Wirtenberger (2006)
10.2174/092986710792231941
Histone variant H2A.Z can serve as a new target for breast cancer therapy.
D. Rangasamy (2010)
10.1016/S1470-2045(04)01653-5
Genomic instability in histologically normal breast tissues: implications for carcinogenesis.
D. Ellsworth (2004)
10.1186/s13058-016-0733-1
Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom
M. Schoemaker (2016)
10.1158/1078-0432.CCR-04-1621
Association of NCOA3 Polymorphisms with Breast Cancer Risk
B. Burwinkel (2005)
10.1007/s10549-017-4325-2
Family history and risk of breast cancer: an analysis accounting for family structure
H. Brewer (2017)
10.1093/ije/dyaa201
Evidence for familial clustering in breast cancer age of onset.
Ann Von Holle (2020)
10.1002/ijc.20370
Polymorphisms and haplotype structures in genes for transforming growth factor β1 and its receptors in familial and unselected breast cancers
Q. Jin (2004)
10.1093/JNCI/DJH106
Tamoxifen and breast density in women at increased risk of breast cancer.
J. Cuzick (2004)
10.1093/CARCIN/BGL067
Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer.
M. Wirtenberger (2006)
10.1002/ijc.21225
c‐MYC Asn11Ser is associated with increased risk for familial breast cancer
M. Wirtenberger (2005)
10.1186/1471-2156-8-68
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies
L. H. M. Pereira (2006)
10.1093/CARCIN/BGG043
A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55.
B. Nexø (2003)
10.1007/S10540-005-2743-6
Yeast and Cancer
L. Hartwell (2004)
10.3233/BD-2004-19102
Genomic approaches to identifying breast cancer susceptibility factors.
J. Struewing (2004)
Survey of Human Papilloma Virus 18 in Breast Epithelium of Iraqi women Using In situ Hybridization Technique
M. Mohamed (2014)
10.1016/J.CANLET.2006.05.002
Aurora kinases A and B and familial breast cancer risk.
S. Tchatchou (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar